Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Report 2026

Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Overview

• Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing market size has reached to $3.95 billion in 2025 • Expected to grow to $5.28 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Increasing Prevalence Of Hospital-Acquired Infections Driving The Growth Of The Market Due To Rising Risk Of Opportunistic Pathogen Transmission In Healthcare Settings • Market Trend: Integration Of Artificial Intelligence In Testing Drives Growth In The Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market?

Methicillin-resistant staphylococcus aureus (MRSA) testing refers to a set of diagnostic procedures used to detect the presence of methicillin-resistant Staphylococcus aureus bacteria in clinical samples to support infection control and treatment decisions. These testing methods typically include molecular diagnostics, culture-based techniques, and immunoassays to ensure accurate and timely identification of resistant strains. They are commonly used in hospitals, diagnostic laboratories, and outpatient settings to prevent the spread of infections and guide appropriate antibiotic therapy. The main types of methicillin-resistant staphylococcus aureus (MRSA) testing include healthcare acquired methicillin resistant staphylococcus aureus, community acquired methicillin resistant staphylococcus aureus, and hospital acquired methicillin resistant staphylococcus aureus. Healthcare acquired methicillin resistant staphylococcus aureus refers to infections identified in patients exposed to healthcare settings such as hospitals or long-term care facilities. These tests are applied across indications such as skin and soft tissue infections (SSTIS), pneumonia, bloodstream infections, surgical and medical infections, and other indications. The various technologies involved are polymerase chain reaction (PCR), real time polymerase chain reaction (RT-PCR), chromogenic media, enzyme linked immunosorbent assay (ELISA), and other technologies, and they are used by several end users such as hospitals, diagnostic laboratories, research institutes, ambulatory care centers, and other end users.

What Is The Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Growth Forecast?

The methicillin-resistant staphylococcus aureus (MRSA) testing market size is expected to see strong growth in the next few years.It will grow to $5.28 billion by 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rising adoption of rapid molecular diagnostic technologies, increasing investment in precision medicine and pathogen genomics, expansion of automated laboratory systems, growing demand for real-time infection surveillance, stricter regulatory focus on antimicrobial resistance control.Major trends in the forecast period include rising adoption of rapid molecular diagnostics for antibiotic resistance detection, increasing use of point-of-care MRSA testing in hospitals, growing implementation of automated microbiology workflows in diagnostic laboratories, expansion of infection surveillance programs in healthcare facilities, increasing demand for multiplex assays for hospital-acquired infection screening.

Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Segmentation

1) By Type: Healthcare Acquired Methicillin Resistant Staphylococcus Aureus, Community Acquired Methicillin Resistant Staphylococcus Aureus, Hospital Acquired Methicillin Resistant Staphylococcus Aureus 2) By Indication: Skin And Soft Tissue Infections (SSTIs), Pneumonia, Bloodstream Infections, Surgical And Medical Infections, Other Indications 3) By Technology: Polymerase Chain Reaction (PCR), Real Time Polymerase Chain Reaction (RT-PCR), Chromogenic Media, Enzyme Linked Immunosorbent Assay (ELISA), Other Technologies 4) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Ambulatory Care Centers, Other End Users Subsegments: 1) By Healthcare Acquired Methicillin Resistant Staphylococcus Aureus: Intensive Care Unit Associated Infections, Catheter Related Infections, Ventilator Associated Infections, Post Surgical Site Infections, Long Term Care Facility Infections 2) By Community Acquired Methicillin Resistant Staphylococcus Aureus: Skin And Soft Tissue Infections, Athlete Associated Infections, Household Transmission Infections, Community Cluster Infections, School And Daycare Associated Infections 3) By Hospital Acquired Methicillin Resistant Staphylococcus Aureus: Surgical Site Infections, Bloodstream Infections, Respiratory Tract Infections, Device Associated Infections, Wound And Burn Infections

What Is The Driver Of The Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market?

The increasing prevalence of hospital-acquired infections is expected to propel the growth of the methicillin-resistant staphylococcus aureus (MRSA) testing industry going forward.Hospital-acquired infections (HAIs) are secondary infections that patients contract while receiving medical or surgical treatment within a healthcare facility.This prevalence is rising globally because the increasing complexity of medical procedures and the high volume of immunocompromised patients create more opportunities for opportunistic pathogens to colonize.Methicillin-resistant staphylococcus aureus (mrsa) testing facilitates the management of these infections by allowing clinicians to identify colonized patients early and implement isolation protocols to prevent facility-wide transmission.For instance, in August 2025, according to the Health Security Agency, a UK-based national executive agency, the overall reported mrsa bacteremia cases reached 81, representing an 8.0% increase compared to 75 cases in August 2024.Therefore, an increasing prevalence of hospital-acquired infections is expected to drive the growth of the methicillin-resistant staphylococcus aureus (MRSA) testing industry.

Key Players In The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market

Major companies operating in the methicillin-resistant staphylococcus aureus (mrsa) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux SA, Hologic Inc., QuidelOrtho Corporation, Bruker Corporation, Bio-Rad Laboratories Inc., QIAGEN N. V., Randox Laboratories Ltd., SD Biosensor Inc., Seegene Inc., Hardy Diagnostics Inc., Alifax S. r. l., Ganesh Diagnostic and Imaging Centre Pvt. Ltd., Uniogen Oy, 3B BlackBio Dx Limited, Orange Health Labs Private Limited

Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Trends and Insights

Major companies operating in the methicillin-resistant staphylococcus aureus (MRSA) testing market are focusing on the integration of artificial intelligence in testing, such as AI-powered imaging analysis, to gain a competitive advantage. AI-powered imaging analysis employs artificial intelligence algorithms to interpret bacterial growth patterns on chromogenic media plates automatically and accurately in MRSA screening workflows. For instance, in May 2023, Becton, Dickinson and Company (BD), a US-based medical technology company, gained FDA 510(k) clearance for the BD Kiestra MRSA Imaging application. This application automates Petri dish inspection for mauve-colored MRSA colonies, enables batch review of negative results, and integrates with BD Synapsys Informatics for efficient worklist organization. Laboratories benefit from reduced turnaround times, minimized labor burdens, and reallocation of staff to complex analyses.

What Are Latest Mergers And Acquisitions In The Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market?

In May 2024, Bruker Corporation, a US-based provider of in-vitro diagnostics, molecular diagnostics, and clinical testing solutions, acquired molecular diagnostics business of ELITechGroup for an undisclosed amount. With this acquisition, Bruker aims to expand its molecular diagnostics capabilities by integrating PCR-based infectious disease testing platforms that support infectious disease detection, including hospital-acquired infections such as Methicillin-resistant Staphylococcus aureus (MRSA), thereby strengthening its position in molecular diagnostics and clinical microbiology markets. ELITechGroup is a France-based provider of molecular diagnostic solutions capable of delivering PCR-based testing solutions for infectious diseases and clinical microbiology applications across hospital and laboratory settings.

Regional Insights

North America was the largest region in the methicillin-resistant staphylococcus aureus (MRSA) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market?

The methicillin-resistant staphylococcus aureus (MRSA) testing market consists of revenues earned by entities by providing services such as hospital laboratory testing, diagnostic lab services, point-of-care testing services, and infection screening programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The methicillin-resistant staphylococcus aureus (MRSA) testing market also includes sales of PCR test kits, culture media and chromogenic agar plates, automated diagnostic instruments, reagents, assay kits, and control materials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Industry?

The methicillin-resistant staphylococcus aureus (mrsa) testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the methicillin-resistant staphylococcus aureus (mrsa) testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Report 2026?

The methicillin-resistant staphylococcus aureus (MRSA) testing market research report is one of a series of new reports from The Business Research Company that provides methicillin-resistant staphylococcus aureus (MRSA) testing market statistics, including methicillin-resistant staphylococcus aureus (MRSA) testing industry global market size, regional shares, competitors with a methicillin-resistant staphylococcus aureus (MRSA) testing market share, detailed methicillin-resistant staphylococcus aureus (MRSA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the methicillin-resistant staphylococcus aureus (MRSA) testing industry. This methicillin-resistant staphylococcus aureus (MRSA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.